Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01295671 · ClinicalTrials.gov registry record · NA
Beverages and Societal Health
A NA study of Cardiovascular Disease, Obesity, sponsored by Boston Children's Hospital.
- Completed
- Registry status
- NA
- Development phase
- 203
- Enrollment target
- 1
- Study location
NCT01295671: Completed NA study of Cardiovascular Disease, Obesity, sponsored by Boston Children's Hospital.
NCT01295671 is a NA study of Cardiovascular Disease, Obesity that has completed, run by Boston Children's Hospital. The registered enrollment target is 203 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01295671, a NA study of Cardiovascular Disease, Obesity, has completed, sponsored by Boston Children's Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 203 participants
- Enrollment target
- 1
- Study location
Study Summary
The overall aim of the study is to compare the effects of three types of beverages - sugar-sweetened (SSB), artificially sweetened (ASB), and unsweetened (USB) - on cardiovascular disease (CVD) risk factors and body weight among young adults.
Conditions Studied
Interventions
- BEHAVIORAL Provision of beverages
Study Locations (1)
Massachusetts
- Children's Hospital Boston - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 203 participants |
| Start Date | 2011-02 |
| Est. Completion | 2015-11 |
| Phase | NA |
What the finished NCT01295671 record still lists
NCT01295671 is an interventional study that assigns participants to a tested intervention. The registered 203 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower).
The record links to 1 condition, with Cardiovascular Disease, Obesity appearing as the primary indexed condition, and to 1 intervention - of which Provision of beverages is the first listed.
NCT01295671 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT01295671 about?
NCT01295671 is a clinical study titled "Beverages and Societal Health". The overall aim of the study is to compare the effects of three types of beverages - sugar-sweetened (SSB), artificially sweetened (ASB), and unsweetened (USB) - on cardiovascular disease (CVD) risk factors and body weight among young adults.
What is the current status of trial NCT01295671?
This trial is currently completed. It is a NA study. The enrollment target is 203 participants. The study started on 2011-02. Estimated completion is 2015-11.
What conditions does trial NCT01295671 study?
This clinical trial studies the following conditions: Cardiovascular Disease, Obesity.
What interventions are being tested in trial NCT01295671?
The interventions under investigation include: Provision of beverages (BEHAVIORAL).
Who is sponsoring clinical trial NCT01295671?
This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01295671 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01295671's enrollment target sits among peer trials
203 504th of 2000 higher than 1,496 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05652686 · 203 participants · Phase 1
A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)
- NCT06063122 · 203 participants · NA
Development of a Therapeutic Device to Improve Speech Sound Differentiation in Preterm Infants
- NCT07031245 · 203 participants · NA
Evidence-Based Quality Improvement to Reduce VA Primary Care Burnout
- NCT03481010 · 204 participants · NA
Periacetabular Osteotomy With and Without Arthroscopic Management of Central Compartment Pathology
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia